Actualités

The stock market bounced but hasn't taken this step while a key risk is growing. SpaceX, AMD, Sandisk, Eli Lilly earnings loom.

Moby summary of Balchem Corporation's Q2 2026 earnings call

Moby summary of Chevron Corporation's Q2 2026 earnings call

U.S. stocks rose despite a rout in Apple shares as Amazon’s earnings kept the artificial-intelligence recovery rolling. The broad S&P 500 gained 52.09 points, or 0.70%, to 7489.72 and the tech-heavy Nasdaq Composite added 251.68 points, or 1%, to 25373.85. The yield on the 30-year bond rose 0.068 percentage point to 5.274%, completing its largest monthly gain since December 2024.

Analysts raised Amazon price targets to as high as $400 after AWS growth of 37% drove a 15% single day surge.

Plus, Tesla considers sale of China business and Anthropic discloses that its software hacked three companies.

AMD’s latest quarterly results are set to be released Tuesday afternoon, with traders anticipating a big move from the chipmaker’s stock.

RBC Delivers Bearish Palantir Warning Ahead of High-Stakes Earnings Report

But yields on the 10-year and 30-year Treasuries hit their highest levels since 2007 Friday, which kept a lid on the stock market's advance.

Corning’s share price has more than tripled over the past three years, yet the current intrinsic value estimate from a Discounted Cash Flow (DCF) model still points to a meaningful gap to the market price. This raises the question of how much of this run is backed by fundamentals and how much is sentiment after the latest sell off. Corning has returned about 3.3x over three years, which puts recent short term share price weakness in the context of a very strong longer term run. Growing...

Procter & Gamble stock has delivered a 14.9% total return over the past 5 years. Current checks suggest the market price may still sit below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and supporting earnings multiples. Over 5 years Procter & Gamble has returned 14.9%, which points to a relatively modest payoff for long term holders compared with many large consumer stocks. Recent headlines around softer revenue trends and cost pressures can weigh on growth...

Airbnb (ABNB) is back in focus as Wall Street looks ahead to its June quarter earnings report on August 6, with expectations centered on higher revenue and year over year earnings growth. See our latest analysis for Airbnb. At a share price of $152.08, Airbnb has posted a 14.34% year to date share price return and a 14.86% total shareholder return over the past year. The recent 10.55% 7 day share price move suggests momentum is building ahead of earnings as investors react to fresh earnings...

Elon Musk's SpaceX (SPCX) is scheduled to release its first earnings report on Tuesday, August 4, since going public in June. Yahoo Finance Senior Transports Reporter Pras Subramanian outlines the areas that investors will be paying the most attention to, especially since SpaceX stock has sunk far below its IPO price.

Magna International (NYSE:MGA) reported stronger second-quarter results for 2026, citing operational improvements, margin expansion and cash generation that led the automotive supplier to raise its full-year outlook. Sales rose 3% year over year to $11 billion in the quarter, while adjusted EBIT in

LyondellBasell Industries (NYSE:LYB) said second-quarter earnings and margins improved sharply as disruptions tied to the Middle East conflict tightened petrochemical supply, altered trade flows and supported pricing across several of its businesses. Chief Executive Officer Peter Vanacker said the

Amazon (AMZN) stock is ripping higher on Friday after the e-commerce and cloud computing giant delivered a blockbuster Q2 report that comfortably exceeded Wall Street's expectations.

Profit growth is finally catching up with market dominance

Exxon's (XOM) second quarter earnings fell short of Wall Street's expectations, despite last quarter's surge in oil (CL=F, BZ=F) prices. Yahoo Finance Breaking Business News Reporter Jake Conley takes a closer look and explains how Chevron (CVX) differs from Exxon.

Investors will watch whether AI-driven demand and defense contracts continue to fuel growth.

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts’ average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised its guidance and stated that it is on track to meet […]

There is more to this stock than meets the eye.

Rivian stock sinks despite strong Q2 and raised delivery guidance. Cantor Fitzgerald continues to see upside in RIVN shares ahead.

Analysts cut Coinbase stock price targets after a third straight miss, yet most still tell clients to buy COIN.

Amazon delivered blockbuster results across the board.

LQDA heads into its Q2 earnings with Yutrepia driving growth, rising profitability and a self-funded pipeline as investors watch quarterly performance.

Eaton (NYSE:ETN) reported record second-quarter revenue and adjusted earnings as demand across its electrical businesses and aerospace segment remained strong, led by data center activity and capacity expansion in Electrical Americas. Chief Executive Officer Paulo Ruiz said adjusted earnings per sh

Enbridge (NYSE:ENB) said it completed the first half of 2026 with a solid second quarter, supported by high utilization across its four business units, and reaffirmed its full-year guidance. The company also outlined a growing project pipeline spanning liquids transportation, natural gas transmissio

Magna International Inc (MGA) posts record Q2 adjusted EPS of $1.86, up 29% year-over-year, and raises full-year 2026 guidance on strong operational execution.

Despite a year-over-year earnings dip, Cameco Corp (CCJ) leverages decade-high uranium prices, a robust contract portfolio, and a growing AP1000 pipeline to position for sustained growth.

Moderna Inc (MRNA) exceeds Q2 revenue guidance and advances key vaccines, but faces delays in norovirus trial and oncology readouts.